• Microdosing Collective Calls for Regulated Microdosing Products in Wake of Diamond Shruumz Recall
    • Ketamine Clinics Los Angeles Anticipates Landmark FDA Decision on MDMA-Assisted Therapy for PTSD
    • Fluence Announces Free Webinar on FDA's MDMA-Assisted Therapy Decision
    Microdosing Collective Calls for Regulated Microdosing Products in Wake of Diamond Shruumz Recall
    News

    Microdosing Collective Calls for Regulated Microdosing Products in Wake of Diamond Shruumz Recall

    Incident highlights urgent need for safe, legal access to sub-perceptual psychedelic use
    Ketamine Clinics Los Angeles Anticipates Landmark FDA Decision on MDMA-Assisted Therapy for PTSD
    News

    Ketamine Clinics Los Angeles Anticipates Landmark FDA Decision on MDMA-Assisted Therapy for PTSD

    Industry Leader Weighs in on Potential Implications for Mental Health Treatment Landscape
    Fluence Announces Free Webinar on FDA's MDMA-Assisted Therapy Decision
    News

    Fluence Announces Free Webinar on FDA's MDMA-Assisted Therapy Decision

    Psychedelic therapy training experts to host  discussion on landmark ruling's implications for PTSD treatment
    Microdosing Collective Calls for Regulated Microdosing Products in Wake of Diamond Shruumz Recall
    Ketamine Clinics Los Angeles Anticipates Landmark FDA Decision on MDMA-Assisted Therapy for PTSD
    Fluence Announces Free Webinar on FDA's MDMA-Assisted Therapy Decision
    News
    Fluence Receives Oregon State License to Train Psilocybin Facilitators

    Oregon’s Higher Education Coordinating Commission (HECC) has licensed Fluence to train psilocybin facilitators under Measure 109

    5 October 2022

    News
    Fireside Project Launches Affinity Program, Matching Callers with BIPOC, Trans, and Veteran Volunteers

    · Fireside Project’s Affinity Program launched on June 23, with volunteers trained to provide psychedelic peer support based on shared identity and life experience

    4 July 2022

    News
    VETS Coaches Publish Psychedelic Integration Scales, Adding a Vital Tool for Therapists and Researchers

    For Immediate Release

    17 June 2022

    News
    “The Light Is Back in My Eyes”:  Testimonials Highlight Beond’s Insight-Oriented Ibogaine Treatment for Addiction and Personal Growth

    Over 20 guests complete treatment at Beond

    10 June 2022

    News
    Homecoming Releases Comprehensive Preparation Program for Ketamine Therapy Providers

    Clinicians can sign up by scheduling a demo or contacting Homecoming at hello@homecoming.health

    8 June 2022

    News
    Wavepaths Launches Listener Community To Expand Access To Music for Self-Exploration

    For the first time, Wavepaths offers a new way of supporting wellbeing and mental health through music from the comfort of one’s own home

    1 June 2022

    News
    Fireside Project Expands to Provide Psychedelic Peer Support Based on Shared Identity and Life Experience

    MEDIA ADVISORY

    27 May 2022

    News
    VETS and Veteran’s PATH Partner to Enhance Psychedelic Therapy with Meditation

    For Immediate Release

    12 April 2022

    News
    VETS Receives $3 Million Endowment to Give Veterans a Lifeline with Psychedelic Therapies

    For Immediate Release

    3 March 2022

    News
    Beond Partners with Renowned Addiction Specialist Dr. Gabor Maté for Discussion of Ibogaine for Addiction Treatment

    Ibogaine Insights discussion series to dive deeply into ibogaine as a treatment for trauma and addiction

    3 March 2022

    Integration Communications

    Industry-leading communications, brand strategy, public relations, media training, professional education, and public education services for companies dedicated to psychedelic therapy, health, and wellness.

    Powered by